Short answer
Aveanna Healthcare Holdings, Inc. (AVAH) filed an 8-K current report with the SEC on August 13, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1), Item 7.01 (Regulation FD Disclosure). Aveanna reported financial results for the three and six months ended July 4, 2026.
Aveanna Healthcare Holdings, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Aveanna reported financial results for the three and six months ended July 4, 2026
- Press release issued August 13, 2026, with detailed results in Exhibit 99.1
- Results update provides investors with the company’s latest operating and financial performance 北京赛车前
Item 7.01 · Regulation FD Disclosure
- Item 7.01 incorporates the company’s Item 2.02 earnings disclosure into this 8-K
- Investor focus: financial results and management commentary contained in the referenced Item 2.02 exhibit
Item EX-99.1 · Exhibit EX-99.1
- Q2 revenue $670.5M, up 13.7%, led by PDS growth of $67.9M and strong expansion across all segments
- Net income $40.3M versus $27.0M, while diluted EPS rose to $0.18 from $0.13
- Adjusted EBITDA $95.4M, up 8.0%, but margin declined to 14.2% from 15.0%
- FY2026 guidance raised to revenue above $2.68B and Adjusted EBITDA above $365M
- Total indebtedness $1.483B, partially offset by $97.2M cash and $110.0M incremental securitization capacity
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Aveanna Healthcare Holdings, Inc. 8-K filings
Get the next AVAH 8-K as it lands
Follow AVAH for push alerts, or ask the research agent what this filing means.